Document Detail


Different G2/M accumulation in M059J and M059K cells after exposure to DNA double-strand break-inducing agents.
MedLine Citation:
PMID:  15708275     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To investigate and compare the cell cycle progression in relation to cell death in the human glioma cell lines, M059J and M059K, after exposure to DNA double-strand break-inducing agents.
METHODS AND MATERIALS: The M059J and M059K cells, deficient and proficient in the catalytic subunit of the DNA-dependent protein kinase, respectively, were exposed to 1 and 4 Gy of photons or accelerated nitrogen ions. In addition, M059J and M059K cells were treated with 10 and 40 mug/mL of bleomycin for 30 min, respectively. Cell cycle progression, monitored by DNA flow cytometry, was measured up to 72 h after treatment.
RESULTS: M059J, but not M059K, cells displayed G(2)/M accumulation after low linear energy transfer irradiation. High linear energy transfer radiation exposure however, resulted in a substantial increase of M059K cells in the G(2)/M phase detected at 48 h. At 72 h, the number of cells in the G(2)/M phase was equivalent to its control. M059J cells accumulated mainly in S phase after high linear energy transfer irradiation. In contrast to M059K, M059J cells were still blocked at 72 h. Bleomycin induced G(2)/M accumulation for both M059J and M059K cells detected 24 h after treatment. At 48 h, the percentage of bleomycin-treated M059J cells in G(2)/M phase remained high, and the number of M059K cells had decreased to control levels. Neither cell line showed cell cycle arrest (< or =10 h) after exposure to these agents.
CONCLUSION: Distinct cell cycle block and release is dependent on the complexity of the induced DNA damage and the presence of the DNA-dependent protein kinase catalytic subunit.
Authors:
Asa Holgersson; Thomas Heiden; Juan Castro; Margareta R Edgren; Rolf Lewensohn; Annelie E Meijer
Related Documents :
1890855 - A theory for analysis of cell populations with non-cycling s phase cells.
3883395 - Influence of different inhibitors on the activity of the rad54 dependent step of dna re...
18843205 - Underlying principles of cell fate determination during g1 phase of the mammalian cell ...
12680725 - Phase response of model sinoatrial node cells.
21374115 - Scale-up of suspension and anchorage-dependent animal cells.
17132155 - Expression of galectin-3 and its regulation in the testes.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  61     ISSN:  0360-3016     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-14     Completed Date:  2005-03-24     Revised Date:  2012-06-25    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  United States    
Other Details:
Languages:  eng     Pagination:  915-21     Citation Subset:  IM    
Affiliation:
Department of Oncology-Pathology, Unit of Medical Radiation Biology, Karolinska Institutet, SE-171 76 Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antimetabolites, Antineoplastic / pharmacology
Bleomycin / pharmacology
Cell Cycle / drug effects,  physiology,  radiation effects*
DNA Damage*
DNA Repair
DNA-Activated Protein Kinase
DNA-Binding Proteins / metabolism
G2 Phase / physiology
Glioma / metabolism,  pathology*
Humans
Linear Energy Transfer
Mitosis / physiology
Nuclear Proteins
Protein-Serine-Threonine Kinases / metabolism
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Antimetabolites, Antineoplastic; 0/DNA-Binding Proteins; 0/Nuclear Proteins; 11056-06-7/Bleomycin; EC 2.7.11.1/DNA-Activated Protein Kinase; EC 2.7.11.1/PRKDC protein, human; EC 2.7.11.1/Protein-Serine-Threonine Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tum...
Next Document:  Hybrid IMRT plans--concurrently treating conventional and IMRT beams for improved breast irradiation...